| __timestamp | Bausch Health Companies Inc. | Galapagos NV |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 9079000 |
| Thursday, January 1, 2015 | 2682700000 | 20309000 |
| Friday, January 1, 2016 | 2810000000 | 16945000 |
| Sunday, January 1, 2017 | 2582000000 | 20559000 |
| Monday, January 1, 2018 | 2473000000 | 29641000 |
| Tuesday, January 1, 2019 | 2554000000 | 88258000 |
| Wednesday, January 1, 2020 | 2367000000 | 162170000 |
| Friday, January 1, 2021 | 2624000000 | 167218000 |
| Saturday, January 1, 2022 | 2625000000 | 239528000 |
| Sunday, January 1, 2023 | 2917000000 | 94252000 |
Cracking the code
In the competitive landscape of the pharmaceutical industry, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. Bausch Health Companies Inc. and Galapagos NV, two prominent players, offer a fascinating study in contrasts. Over the past decade, Bausch Health has consistently maintained SG&A expenses around 2.6 billion USD annually, peaking at 2.9 billion USD in 2023. This represents a steady increase of approximately 44% from 2014. In contrast, Galapagos NV, with a more modest SG&A budget, saw a dramatic rise from 9 million USD in 2014 to nearly 240 million USD in 2022, a staggering increase of over 2500%. This divergence highlights differing strategic priorities and operational scales. As Bausch Health focuses on maintaining its expansive operations, Galapagos NV's rapid growth in SG&A spending suggests aggressive expansion and investment in its future capabilities.
Sanofi and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Gilead Sciences, Inc. vs Galapagos NV Trends and Insights
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Bausch Health Companies Inc.
Operational Costs Compared: SG&A Analysis of Viatris Inc. and Bausch Health Companies Inc.
Bio-Techne Corporation vs Galapagos NV: SG&A Expense Trends
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Bausch Health Companies Inc.
Walgreens Boots Alliance, Inc. or Galapagos NV: Who Manages SG&A Costs Better?
Cytokinetics, Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Apellis Pharmaceuticals, Inc. or Bausch Health Companies Inc.
Bausch Health Companies Inc. or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Galapagos NV Trends and Insights